Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
This report describes a case of Epstein-Barr [correction of Epstein Barr] Virus related post-transplantation B lymphoproliferative disease of unusual Burkitt lymphoma (BL) type in which combined cytotoxic agents (PACE BOM) successfully produced complete and long-term tumor remission.
Hunt
B J
BJ
Cardiothoracic Transplant Unit, Harefield Hospital, Middlesex, United Kingdom.
Thomas
J A
JA
Burke
M
M
Walker
H
H
Yacoub
M
M
Crawford
D H
DH
D000493:Allopurinol / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D016572:Cyclosporine / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D016027:Heart Transplantation; D006566:Herpesviridae Infections; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology*; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D014412:Tumor Virus Infections; D014750:Vincristine / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D003561:Cytarabine; D001761:Bleomycin; D014750:Vincristine; D000493:Allopurinol; D005047:Etoposide; D004317:Doxorubicin; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D008727:Methotrexate